China Medical System Holdings Insider Ups Holding During Year
China Medical System Holdings Insider Ups Holding During Year
From what we can see, insiders were net buyers in China Medical System Holdings Limited's (HKG:867 ) during the past 12 months. That is, insiders acquired the stock in greater numbers than they sold it.
從我們能看到的情況來看,內部人士在中國醫療系統控股有限公司(HKG:867)在過去12個月裏是淨買入的。也就是說,內部人士購買的股票數量大於他們出售的數量。
While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, logic dictates you should pay some attention to whether insiders are buying or selling shares.
雖然我們絕不會建議投資者僅僅根據公司的董事們所做的事情來做出決策,但邏輯上你應該關注內部人士是否在買入或賣出股票。
China Medical System Holdings Insider Transactions Over The Last Year
中國醫藥系統控股過去一年的內部交易情況
In the last twelve months, the biggest single purchase by an insider was when Founder Kong Lam bought HK$7.3m worth of shares at a price of HK$7.32 per share. That means that an insider was happy to buy shares at around the current price of HK$7.78. Of course they may have changed their mind. But this suggests they are optimistic. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. The good news for China Medical System Holdings share holders is that an insider was buying at near the current price. Kong Lam was the only individual insider to buy shares in the last twelve months.
在過去十二個月中,內部人士最大的單筆購買是在創始人Kong Lam以每股HK$7.32的價格購買了價值730萬港元的股票。這意味着內部人士願意以當前價格約爲HK$7.78購買股票。當然,他們可能改變了主意。但這表明他們持樂觀態度。如果有人以遠低於當前價格的水平購買股票,這整體上是個好跡象,但請記住,他們可能不再認爲有價值。對中國醫療系統控股股東來說,好消息是有一位內部人士在接近當前價格時購買了股票。在過去的十二個月裏,Kong Lam是唯一一位購買股票的內部人士。
Kong Lam purchased 30.00m shares over the year. The average price per share was HK$7.14. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
Kong Lam在過去一年內購買了3000萬股。每股平均價格爲HK$7.14。您可以在下面的圖表中查看過去一年內部交易(由公司和個人進行)。如果您點擊圖表,您可以查看所有個別交易,包括股價、個人以及日期!

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying.
還有很多其他公司內部人士正在買入股票。你可能不想錯過這份內部人士正在購買的被低估的小盤公司的免費名單。
Insider Ownership Of China Medical System Holdings
中國醫療系統控股股權內幕
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. We usually like to see fairly high levels of insider ownership. China Medical System Holdings insiders own about HK$9.7b worth of shares (which is 52% of the company). Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.
測試公司領導層與其他股東之間一致性的一種方法是查看他們擁有多少股份。我們通常希望看到相對較高的內部持股比例。中國醫療系統控股的內部人士持有約97億港元的股份(佔公司52%)。大多數股東會對這種內部持股表示滿意,因爲這表明管理層的激勵與其他股東的利益較爲一致。
So What Does This Data Suggest About China Medical System Holdings Insiders?
那麼這些數據對中國醫療系統控股內部人有何建議?
It's certainly positive to see the recent insider purchase. And an analysis of the transactions over the last year also gives us confidence. When combined with notable insider ownership, these factors suggest China Medical System Holdings insiders are well aligned, and quite possibly think the share price is too low. One for the watchlist, at least! While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. At Simply Wall St, we found 2 warning signs for China Medical System Holdings that deserve your attention before buying any shares.
看到最近的內部購股顯然是積極的。對過去一年交易的分析也讓我們充滿信心。當結合顯著的內部持股比例時,這些因素表明中國醫療系統控股的內部人士是一致的,並且很可能認爲股價過低。至少可以把它放入自選列表!雖然了解內部人士的持股和交易情況很重要,但在做出任何投資決策之前,我們也要考慮股票面臨的風險。在Simply Wall St,我們發現中國醫療系統控股有2個警告信號值得您在購買任何股份之前關注。
Of course China Medical System Holdings may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
當然,中國醫療系統控股可能不是最好的購股選擇。因此,您可能希望查看這一系列高質量公司的免費集合。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
在本文中,內部人士是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall St的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St在提到的任何股票中均沒有持倉。